Skip to content

Released May 14, 2020, after the close

10-Q filed May 14, 2020, 44 days after period end · 0001390478-20-000014

Q1 2020 · 10-Q
Revenue$0.00no prior Q1 2019 on fileno prior Q4 2019 on file
Net Income-$4.14MN/M vs Q1 2019N/M vs Q4 2019
EPS Diluted-$0.66N/M vs Q1 2019no prior Q4 2019 on file
Operating Income-$4,064,000—
Operating Cash Flow-$6,831,000N/M

What the release said

The release

Same quarter

MetricQ1 2020Q1 2019Q1 2018Q1 2017
Revenue$0.00———
Net Income-$4.14M-$4.54M-$8.00M-$4.60M
EPS Diluted-$0.66-$11.12-$1.67-$3.63

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR